MOUNTAIN VIEW, Calif., Jan. 10, 2011 /PRNewswire/ — Hotspur
Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and
Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink
Interventional Center in Modesto, California, performed the first
commercial deployment of the company’s GPSCath™ Balloon
Dilatation Catheter. This new device enables, for the first
time, multiple vascular procedures to be performed with one
catheter, potentially reducing procedure time and expense for both
patients and medical professionals.
The GPSCath™ is a two-in-one device that allows physicians
to perform high-pressure angioplasty and inject physician-specified
fluids such as contrast while maintaining guidewire position.
“The Hotspur GPSCath™ balloon is a superior alternative to
a non-compliant ultra-high-pressure legacy devices currently in
use,” said Dr. Lin. “This is because the flexible nature of the
Hotspur device allows tactile and visual feedback on the stenotic
lesion, while still providing the performance of a
ultra-high-pressure angioplasty balloon. In addition, the
value added feature enables operators to conveniently maintain
guidewire position while delivering therapeutic drugs and
evaluating results of interventions. This is especially attractive
when treating difficult or occlusive lesions. Hotspur is
setting a higher bar for peripheral and dialysis access angioplasty
performance.”
During the first procedure, Dr. Liu successfully restored blood
flow through the patient’s dialysis access graft by inflating a 7mm
GPSCath™ balloon to 20ATM to open a blockage within the
graft. After performing the angioplasty, without removing the
balloon, Dr. Liu then opened the proprietary valve on the distal
end of the GPSCath™ balloon catheter and successfully
injected contrast to visualize the angioplasty result. Dr. Liu
followed with a second procedure performing both functions
utili
‘/>”/>
